A Nanoengineering Scheme Aims to Make Drugs More Effective by Fooling the Immune System
In this backstage interview at EmTech, 2013 Innovator Under 35 Liangfang Zhang describes his research that has uncovered a new way to remove toxins from the bloodstream via red blood cell decoy armies.
Watch: Liangfang Zhang on stage at EmTech
Read: 2013 Innovators Under 35 profile of Liangfang Zhang
Keep Reading
Most Popular
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.